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ABSTRACT
Non-natural amino acids have been genetically
encoded in living cells, using aminoacyl-tRNA
synthetase–tRNA pairs orthogonal to the host trans-
lation system. In the present study, we engineered
Escherichia coli cells with a translation system
orthogonal to the E. coli tyrosyl-tRNA synthetase
(TyrRS)–tRNA
Tyr pair, to use E. coli TyrRS variants
for non-natural amino acids in the cells without
interfering with tyrosine incorporation. We showed
that the E. coli TyrRS–tRNA
Tyr pair can be function-
ally replaced by the Methanocaldococcus jannaschii
and Saccharomyces cerevisiae tyrosine pairs, which
do not cross-react with E. coli TyrRS or tRNA
Tyr. The
endogenous TyrRS and tRNA
Tyr genes were then
removed from the chromosome of the E. coli cells
expressing the archaeal TyrRS–tRNA
Tyr pair. In this
engineered strain, 3-iodo-L-tyrosine and 3-azido-L-
tyrosine were each successfully encoded with the
amber codon, using the E. coli amber suppressor
tRNATyr and a TyrRS variant, which was previously
developed for 3-iodo-L-tyrosine and was also found
to recognize 3-azido-L-tyrosine. The structural basis
for the 3-azido-L-tyrosine recognition was revealed
by X-ray crystallography. The present engineering
allows E. coli TyrRS variants for non-natural amino
acids to be developed in E. coli, for use in both
eukaryotic and bacterial cells for genetic code
expansion.
INTRODUCTION
The repertoire of genetically encoded amino acids
has been expanded in Escherichia coli, yeast, insect and
mammalian cells, with the purpose of increasing the
chemical and structural diversity in proteins (1–6).
The genetically encoded ‘non-natural’ amino acids have
unique chemical groups and functionalities not found
among the 20 canonical amino acids, such as heavy
atoms, photo-reactive linkers, ﬂuorescent groups and
chemical groups for site-speciﬁc labeling (7). The incorpo-
ration of these novel structures into proteins at desired
sites promises to facilitate protein science and engineering.
The genetic encoding of a non-natural amino acid
requires the development of an aminoacyl-tRNA
synthetase (aaRS)–tRNA pair speciﬁc to the amino acid.
To date, several aaRS species have been engineered to rec-
ognize useful non-natural amino acids, and among these,
the majority are L-tyrosine or L-phenylalanine derivatives
recognized by variants of tyrosyl-tRNA synthetase
(TyrRS) (7). In living cells, non-natural amino acids are
encoded with the amber codon in most cases, by using the
amber suppressor tRNA–aaRS pair from a diﬀerent
organism that does not cross-react with the endogenous
tRNA or aaRS (8). The bacterial TyrRS, for example,
does not recognize the tRNA
Tyr molecules from
eukaryotes or archaea, while the TyrRS molecules from
these two kingdoms do not recognize the bacterial
tRNA
Tyr. In fact, the bacterial TyrRS–tRNA
Tyr pair
does not cross-react with the endogenous tRNA and
aaRS species in eukaryotic host cells, and has been used
to achieve the site-speciﬁc incorporation of L-tyrosine
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On the other hand, the genetic encoding of L-tyrosine
derivatives in E. coli cells was achieved using the
TyrRS–tRNA
Tyr pair from Methanocaldococcus jannaschii
(1,7). Thus, the E. coli and archaeal TyrRS–tRNATyr
pairs are used in eukaryotic and E. coli cells, respectively.
Other aaRSs, such as tryptophanyl-tRNA synthetase (11),
phenylalanyl-tRNA synthetase (5,12), leucyl-tRNA
synthetase (13) and lysyl-tRNA synthetase (14), also
take advantage of the orthogonal tRNA speciﬁcities
across diﬀerent kingdoms.
Pyrrolysyl-tRNA synthetase (PylRS) diﬀers from these
aaRS species, in that the PylRS–tRNA
Pyl pair from
Methanosarcina mazei is reportedly orthogonal to both
the E. coli and eukaryotic translation systems (15–17).
Archaeal PylRS variants can be developed in E. coli
cells, and are then used for incorporating L-lysine deriva-
tives into proteins in E. coli, yeast and mammalian cells
(16–20). With this advantage, the PylRS–tRNA
Pyl pair is a
promising system for genetic code expansion.
The usefulness of E. coli TyrRS variants would also be
increased, if the E. coli translation system could be engi-
neered to be orthogonal to the E. coli TyrRS–tRNA
Tyr
pair. This modiﬁcation to E. coli cells may be achieved
by substituting an archaeal or eukaryal tyrosine pair for
the endogenous tyrosine pair.
In the present study, the genes encoding TyrRS and
tRNA
Tyr were disrupted in the chromosome of the
E. coli cells expressing the M. jannaschii TyrRS–
tRNA
Tyr pair. The engineered cells then hosted the
E. coli pair of a TyrRS variant and the amber suppressor
tRNA
Tyr, to genetically encode either 3-iodo-L-tyrosine or
3-azido-L-tyrosine, depending on the presence of the cor-
responding amino acid in the growth medium. This TyrRS
variant, designated as iodoTyrRS-ec, was originally
developed for 3-iodo-L-tyrosine (21), and has been used
for the site-speciﬁc incorporation of this amino acid into
proteins in mammalian cells (2,22). We found that
iodoTyrRS-ec also recognizes 3-azido-L-tyrosine, and the
structural basis for its recognition by this variant was
elucidated by X-ray crystallography.
MATERIALS AND METHODS
Strains, growth conditions, growth rate, reagents and
non-natural amino acids
Escherichia coli strains TOP10, BL21(DE3) and DH5a
were purchased from Invitrogen, Novagen and Toyobo
(Tokyo, Japan), respectively. Kanamycin (Km)
(30mg/ml), chloramphenicol (Cm) (34mg/ml), ampicillin
(Amp) (10mg/ml), Zeocin (25mg/ml), L-arabinose (0.2%,
w/v) and D-glucose (0.4%, w/v) were added to LB media
as indicated, except that Cm was added at a concentration
of 25mg/ml when non-natural amino acids were incorpo-
rated into proteins. The growth rate was monitored as the
change in the natural logarithm of the optical density at
600nm of the culture per hour. Zeocin was purchased
from InvivoGen (San Diego, USA). 3-Iodo-L-tyrosine
was purchased from Sigma-Aldrich. 3-Bromo-L-tyrosine,
3-azido-L-tyrosine and the chemical conjugate between
triarylphosphine and ﬂuorescein were commercially
synthesized by Shinsei Chemical Company Ltd (Osaka,
Japan).
Plasmids
The E. coli, M. jannaschii and Saccharomyces cerevisiae
TyrRS genes, and the variant gene encoding iodoTyrRS-
ec, were cloned with the tyrS promoter into pACYC184
(Nippon Gene Co. Ltd., Japan) to create pEcYS, pMjYS,
pScYS and pEcIYS, respectively. The wild-type TyrRS
genes with the promoter were also cloned in an
ampicillin-resistant ColIb-P9 plasmid, pAp102 (23), to
create pApEcYS, pApMjYS and pApScYS, respectively.
The archaeal and yeast tRNA
Tyr genes were cloned with
the tyrT promoter into pACYC184, to create pMjYR and
pScYR, respectively. These tRNA
Tyr genes with the
promoter were also cloned in pMjYS and pScYS, to
create pMjYSYR and pScYSYR, respectively. Three
copies of these tRNA
Tyr genes were cloned after the
tyrT promoter in pAp102, to create pApMjYR and
pApScYR, respectively. The archaeal and yeast TyrRS
genes with the tyrS promoter were cloned in these
plasmids, pApMjYR and pApScYR, to create
pApMjYSYR and pApScYSYR, respectively. The
kanamycin resistance (kam) gene was cloned in the
‘amber suppressor control’ plasmid from the Interchange
amber suppressor in vivo mutagenesis system (Promega),
to create the plasmid pACamK. The resulting plasmid
carries the replication origin of pACYC184 and an
amber mutant chloramphenicol acetyltransferase (CAT)
gene, in addition to the cloned kam gene. The E. coli
amber suppressor tRNA
Tyr gene was cloned with the
tyrT promoter into pACamK, to create the plasmid
pACamKsupF.
To create the plasmid pMJY, the coding sequence of the
Zeocin resistance gene was ampliﬁed by polymerase chain
reaction (PCR) from the vector pcDNA4/TO (Invitrogen).
The sequence 50-ACGACTCACTATAGGAGGGCC-30,
in which the ribosome-binding site (RBS) is underlined,
was added at the 50-end of the coding sequence. The
ampliﬁed gene was cloned between the SspI–PstI sites of
the pBR322 vector, downstream of the promoter of the
ampicillin resistance gene and in place of this gene, to
create the plasmid pBRZeo. The M. jannaschii TyrRS
and tRNA
Tyr genes with the tyrS and tyrT promoters,
respectively, were cloned in pBRZeo to obtain pMJY.
For incorporating non-natural amino acids into
proteins, the E. coli amber suppressor tRNA
Tyr gene
with the tyrT promoter was cloned in pAp102 to create
pApsYR. The replication origin and the ampicillin resis-
tance gene in the plasmid pGEX-4T-3 (GE Healthcare)
were replaced with the origin and kam gene from the
vector pRSF-1b (Novagen), to create the plasmid
pRGexGST. The resulting plasmid retains the glutathione
S-transferase (GST) gene under the control of the tac
promoter. Then, the tyrosine codon at position 84 of
GST was mutated to the amber codon, to create
pRGexGST(Am84). The wild-type gst gene and its
mutant with the amber codon at position 25 (24) were
cloned after the T7 promoter in pRSF-1b to create
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calmodulin gene and its mutant with the amber codon at
position 80 (25) were also cloned after the T7 promoter in
pRSF-1b, to create pRSFCAM and pRSFCAM(Am80),
respectively.
Construction of the conditional tyrS mutant by
chromosome engineering
All of the modiﬁcations to the E. coli chromosome were
made using the RT/ET kit (Gene Bridges GmbH,
Germany), which utilizes the bacteriophage  recombina-
tion system to promote homologous recombination
(26,27). The DNA encoding the RBS, the araBAD
promoter and the araC gene—designated as the ara
block—was introduced into the chromosome in place of
the tyrS promoter. For this engineering, the ara block was
ampliﬁed by PCR from the pBAD/His vector (Invitrogen)
with the primers 50-GGTTAATTCCTCCTGTTAGC-30
and 50-CCAATTATGACAACTTGACG-30. The right-
hand arm (rhm) corresponding to the ﬁrst 50nt of the
tyrS coding sequence was then added at the RBS end of
the ara block. The kam gene with the promoter was
ampliﬁed from the plasmid pHSG299 (Takara Bio Inc.,
Japan), and the rrnC terminator was added downstream
of the kam gene. The left-hand arm (lhm) with the
sequence from 160- to 110-nt upstream the tyrS coding
region (50-ATGCGTGGAAGATTGATCGTCTTGCAC
CCTGAAAAGATGCAAAAATCTTG-30) was added to
the kam gene after the terminator. Then, the kam gene and
the ara block were linked with each other at the ends
opposite to lhm or rhm. The resulting double-stranded
DNA fragment consists of lhm, kam, araC, the araBAD
promoter, RBS and rhm in this order, and was used to
replace the promoter and RBS of tyrS in the chromosome.
The substitution was conﬁrmed by a sequence analysis of
the tyrS locus.
Engineering of the tyrS, tyrT, tyrU and tyrV loci in the
E. coli chromosome
The cat gene with the promoter was ampliﬁed from
pACYA184, using the primers A (50-ACCCGACGCAC
TTTGCGCCG-30) and B (50-TTACGCCCCGCCCTGC
CACTC-30), while the gene without a promoter was
ampliﬁed using primer B and another primer (50-GATT
TTCAGGAGCTAAGGAAGC-30). In the following
experiments, the cat gene was introduced into the chro-
mosome in the same direction as the genes to be replaced.
To disrupt tyrS, the sequences lhm-S (50-ATGCGTGGA
AGATTGATCGTCTTGCACCCTGAAAAGATGCAA
AAATCTTG-30) and rhm-S (50-ACAGGGAACATGAT
GAAAAATATTCTCGCTATCCAGTCTCACGTTGT
TTA-30) were added at the 50- and 30-ends, respectively, of
the cat gene with the promoter. To disrupt tyrT and tyrV,
lhm-T1 (50-AAAATAACTGGTTACCTTTAATCCGTT
ACGGATGAAAATTACGCAACCAG-30) and rhm-T
(50-AGTCCCTGAACTTCCCAACGAATCCGCAATT
AAATATTCTGCCCATGCGG-30) were added at the 50-
and 30-ends, respectively, of the cat gene with the
promoter. To disrupt tyrU, lhm-U (50- GTAATCAGTA
GGTCACCAGTTCGATTCCGGTAGTCGGCACCAT
CAAGTCC-30) and rhm-U (50-GGCCACGCGATGGCG
TAGCCCGAGACGATAAGTTCGCTTACCGGCTCG
AA-30) were added at the 50- and 30-ends, respectively, of
the cat gene without the promoter.
The knocked-in cat gene was removed using a linear
DNA fragment consisting of the lhm and rhm sequences
linked directly to each other. Cells deprived of cat were
selected in the growth media supplemented with Cm
(10mg/ml) and ampicillin (200mg/ml). The cells that are
resistant to Cm and are able to grow in this medium
should undergo lysis in the presence of ampicillin, while
only sensitive cells should survive. The colonies formed by
the surviving cells were replicated on an LB plate contain-
ing Cm (10mg/ml), to check for the sensitivity to Cm.
The E. coli amber suppressor tRNA
Tyr was introduced
into the chromosome in place of the knocked-in cat in the
tyrU locus, using a linear DNA consisting of lhm-U,
the tRNA coding sequence and rhm-U in this order. For
the introduction of the suppressor tRNA
Tyr in the tyrT
and tyrV loci, the cat gene was ﬁrst introduced into these
loci, with lhm-T2 (50-ACTTTACAGCGGCGCGTCATT
TGATATGATGCGCCCCGCTTCCCGATAAG-30) and
rhm-T at the 50- and 30-ends, respectively. Then, the
knocked-in cat gene was replaced by the sequence
encoding the suppressor tRNA, ampliﬁed using primers
(50-TAATTCACCACAGCGATGTG-30 and 50-TTTGA
AAGTGATGGTGGTGG-3) from the genomic DNA of
a supF strain, in which the tyrV gene was mutated to the
amber suppressor tRNA
Tyr.
Site-speciﬁc incorporation of non-natural amino acids
into proteins
FT3 cells were transformed with pEcIYS, pApsYR and
pRGexGST(Am84), and were grown in medium contain-
ing Cm, Amp and Km. The expression of the gst gene was
induced by the addition of IPTG (1mM, ﬁnal), and at the
same time, 3-iodo-L-tyrosine (0.3mg/ml, ﬁnal) was added
to the medium. FB3 cells were transformed with pEcIYS
and either pRSFGST(Am25) or pRSFCAM(Am80), and
were grown in medium containing Kam and Cm.
The expression of the recombinant proteins was induced
with IPTG (1mM, ﬁnal), and at the same time, 3-iodo-L-
tyrosine or 3-azido-L-tyrosine (0.3mg/ml, ﬁnal) was added
to the medium. Labeling with the triarylphosphine-
ﬂuorescein conjugate was performed as described
previously (20,25). Fluorescence from an SDS-gel was
detected using an image analyzer, LAS-1000 (Fuji Film,
Japan). Mass scpectrometric analysis was commercially
performed by Shimadzu Biotech (Japan).
Structure determination
The iodoTyrRS-ec catalytic domain (residues 1–322) was
prepared as described previously (28). The samples were
dialyzed against 20mM Tris–Cl (pH 7.5) containing
50mM NaCl, 10mM 2-mercaptoethanol and 1mM
3-azido-L-tyrosine, and then they were concentrated to
4–6mg/ml with an Amicon Ultra 4 (Millipore).
Crystallization of the complex between iodoTyrRS-ec
and 3-azido-L-tyrosine was performed as described (28).
The samples and crystals were shaded to avoid the
3684 Nucleic Acids Research, 2010,Vol.38, No. 11photolysis of 3-azido-L-tyrosine. The X-ray diﬀraction
experiment of the crystals was performed at the
beamline BL26B1 at SPring-8 (Harima, Japan).
The data were processed with HKL2000 (29).
The iodoTyrRS-ec–3-azide-L-tyrosine structure was deter-
mined by molecular replacement with the program Molrep
(30), using the structure of the complex between
iodoTyrRS-ec and 3-iodo-L-tyrosine (28) as a search
model. The reﬁnement and model building were per-
formed as described (28). The model of 3-azido-L-
tyrosine was generated by the Dundee PRODRG2
server (31).
RESULTS AND DISCUSSION
Complementation of a conditional E. coli tyrS mutant by
the archaeal and eukaryal TyrRS–tRNA
Tyr pairs
We examined whether the translational function of E. coli
TyrRS can be replaced with that of a eukaryal or archaeal
TyrRS–tRNA
Tyr pair in E. coli cells. The expression
system for the arabinose operon was used to control the
expression of the chromosomal tyrS gene encoding E. coli
TyrRS. The araBAD promoter, together with the araC
gene, was introduced into the chromosome in place of
the tyrS promoter, to allow the induction of TyrRS
expression with L-arabinose. Transcription from the
araBAD promoter is tightly repressed in the presence of
D-glucose (32); the created conditional tyrS mutant of
E. coli grew in the presence of L-arabinose, but did not
grow in the presence of D-glucose (Supplementary Figure
S1A). Then, the mutant was transformed with the
multicopy vector pACYA184, and then reproduced the
conditional growth (Supplementary Figure S1B). This
conditional growth was complemented by the tyrS gene
carried on the multicopy plasmid pEcYS, derived from
pACYC184 (Supplementary Figure S1B). On the other
hand, no complementation was observed with either the
multicopy plasmid pMjYS carrying the M. jannaschii
TyrRS gene or the multicopy plasmid pScYS carrying
the S. cerevisiae TyrRS gene; these genes were expressed
from the tyrS promoter (Figure 1A). This observation is
consistent with the reports that these archaeal and
eukaryal TyrRS species do not recognize E. coli
tRNA
Tyr (8,33).
Next, the archaeal and eukaryal TyrRS species were
expressed, together with their cognate tRNA
Tyr species,
from the multicopy plasmids pMjYSYR and pScYSYR,
respectively. In these plasmids, the tRNA
Tyr genes were
placed after the promoter of the tyrT gene, which is one of
three genes encoding E. coli tRNA
Tyr. These plasmids
were found to complement the tyrS mutant (Figure 1A),
indicating that the function of the endogenous TyrRS in
E. coli can be substituted by the archaeal and eukaryal
TyrRS–tRNA
Tyr pairs, which are each orthogonal to the
host translation system.
To determine whether the overproduction of these
TyrRS–tRNA
Tyr pairs from multicopy plasmids is neces-
sary for the complementation, we used the low-copy
plasmid pAp102 (23) to introduce the tyrosine pairs into
the tyrS mutant. This plasmid has the ColIb-P9
replication origin and its copy number is 1.7 per cell
(34). In a control experiment, the vector pAp102 did not
complement the tyrS mutant, while a pAp102-derived
plasmid carrying the tyrS gene (pApEcYS) displayed the
complementing activity (Supplementary Figure S1B). The
M. jannaschii and S. cerevisiae TyrRS genes were then
each cloned in this low-copy vector, together with three
copies of their cognate tRNA
Tyr genes, to create the
plasmids pApMjYSYR and pApScYSYR, respectively.
Neither of these plasmids showed the complementing
activity (Supplementary Figure S1C), indicating that
these exogenous TyrRS or tRNA
Tyr molecules must be
expressed from a multicopy plasmid.
We then determined which molecule, TyrRS or
tRNA
Tyr, needed to be overproduced. First, for the
M. jannaschii tyrosine pair, the enzyme was expressed
from the multicopy plasmid pMjYS, with the tRNA
Tyr
being expressed from the low-copy plasmid pApMjYS.
No complementing activity was observed for this pair of
plasmids (Supplementary Figure S1D). Next, TyrRS was
expressed from the low-copy plasmid pApMjYS, with the
tRNA
Tyr expressed from the multicopy plasmid pMjYR,
but again, no complementation was detected
(Supplementary Figure S1D). These observations
indicated that the complementation requires the
overproduction of both the archaeal TyrRS and
tRNA
Tyr molecules.
We also expressed S. cerevisiae TyrRS from either the
multicopy plasmid pScYS, with the yeast tRNA
Tyr being
expressed from the low-copy plasmid pApScYR, or the
low-copy plasmid pApScYS, with the tRNA
Tyr being
expressed from the multicopy plasmid pScYR. Neither
combination achieved the complementation
(Supplementary Figure S1D), indicating that both the
yeast TyrRS and tRNA
Tyr need to be overproduced.
Similar complementation tests were performed for the
yeast TyrRS–tRNA
Tyr pair at 30 C, the normal growth
temperature for yeast. However, no complementation was
observed (data not shown), indicating that the optimal
temperature for these molecules is probably not relevant
to the requirement of the overproduction of the TyrRS–
tRNA
Tyr pair. Although the reason why the exogenic
tyrosine pairs must be overproduced is not clear, this
requirement is consistent with a recent report showing
that the overproduction of the M. jannaschii TyrRS–
tRNA
Tyr pair in E. coli cells is prerequisite for the eﬃcient
incorporation of non-natural amino acids into proteins (35).
Replacement of the E. coli TyrRS–tRNA
Tyr pair by the
M. jannaschii pair in an E. coli strain
The TyrRS and tRNA
Tyr genes were removed from the
chromosome in an E. coli K12 strain expressing the
M. jannaschii tyrosine pair from the multicopy plasmid
pMJY, constructed as described in the ‘Materials and
Methods’ section (Figure 1B). First, the CAT gene was
introduced into the chromosome in place of the tyrS
gene by homologous recombination. Then, the cat gene
was removed from the chromosome to create the strain
FT1 [TOP10 DtyrS pMJY]. A DNA fragment including
the tyrS locus was ampliﬁed from this strain and analyzed
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of the E. coli TyrRS activity in this strain was also con-
ﬁrmed by expressing the E. coli amber suppressor
tRNA
Tyr, together with a cat amber mutant gene, from
the plasmid pACamKsupF. This plasmid conferred
chloramphenicol resistance to the parent strain TOP10,
but not to FT1 cells (Figure 1C), showing that the
E. coli TyrRS activity was absent in FT1 cells, and that
the E. coli suppressor tRNA
Tyr is orthogonal to the trans-
lation system of the cell.
Next, we removed all three of the E. coli tRNA
Tyr genes
from the chromosome of the FT1 cells. Two of them, tyrT
and tyrV, are located close to each other on the E. coli
chromosome, and share the tyrT promoter for expression.
The cat gene was introduced into the chromosome of FT1
in place of these genes and their promoter, and the
knocked-in cat gene was then removed to create the
strain FT2 [TOP10 DtyrS DtyrT DtyrV pMJY]. A DNA
fragment encompassing the tyrT and tyrV loci was
ampliﬁed from this strain and analyzed to conﬁrm the
disruption of these tRNA
Tyr genes and the tyrT
promoter. Then, to remove the tyrU gene, which is the
third copy of the tRNA
Tyr gene and is co-transcribed
with two tRNA
Thr species and a tRNA
Gly, the cat gene
without a promoter was introduced into the chromosome
of FT2 in place of tyrU, for transcription together with the
other tRNAs. The cat gene was then removed to create
the strain FT3 [TOP10 DtyrS DtyrT DtyrU DtyrV pMJY].
The absence of the tRNA
Tyr gene in the tyrU locus was
conﬁrmed by a sequence analysis.
In order to show that the strain FT3 lacks E. coli
tRNA
Tyr activity, we expressed iodoTyrRS-ec,a nE. coli
TyrRS variant that recognizes 3-iodo-L-tyrosine, and
investigated growth inhibition. When 3-bromo-L-tyrosine
was added to the growth media, the growth rate of DH5a
cells, an E. coli K-12 stain, overproducing the variant was
signiﬁcantly reduced, as compared to that of the cells
overproducing the wild-type E. coli TyrRS (Figure 2A).
This observation suggested that iodoTyrRS-ec is able to
eﬃciently attach 3-bromo-L-tyrosine to the E. coli
tRNA
Tyr, and to inhibit the growth by randomly
incorporating this amino acid into proteins at tyrosine
positions. On the other hand, strain FT3 is immune to
this growth inhibition (Figure 2C), which requires the
interaction between iodoTyrRS-ec and E. coli tRNA
Tyr,
and this observation indicates the absence of the E. coli
tRNA
Tyr in the cell. Thus, the E. coli translation system
was successfully engineered to be orthogonal to the E. coli
TyrRS–tRNA
Tyr pair.
The iodoTyrRS-ec–E. coli suppressor tRNA
Tyr pair
site-speciﬁcally incorporates 3-iodo-L-tyrosine into
proteins in FT3 cells
We used iodoTyrRS-ec to incorporate 3-iodo-L-tyrosine
into proteins at the amber position in the strain FT3.
This TyrRS variant was expressed from the tyrS
promoter on the multicopy plasmid pEcIYS, which is
compatible with pMJY expressing the archaeal tyrosine
pair. Since the expression of the E. coli amber suppressor
tRNA
Tyr from a multicopy plasmid negatively aﬀected the
growth of the E. coli cells, the tRNA gene was expressed
from the low-copy plasmid pApsYR. The gene encoding
GST with an interrupting amber codon was carried on the
third plasmid pRGexGST(Am84). Thus, it was necessary
Figure 1. The tyrS complementation tests with pMjYS, pScYS, pMjYSYR and pScYSYR (A). The mutant cells transformed with these plasmids
were inoculated on the LB plates containing 1% D-glucose and 34 mg/ml Cm. The three sectors of each half plate represent dilutions of the cells.
An illustration of the genetic modiﬁcations and plasmid systems in FT3 and FB3 cells (B). The absence of the E. coli TyrRS activity in the strain
FT1 (C). TOP10 and FT1 cells were each transformed with pACamKsupF and were then inoculated on the LB plate with 10mg/ml Cm.
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site-speciﬁc incorporation of non-natural amino acids
into proteins. The gst amber mutant gene produced the
full-length product only when 3-iodo-L-tyrosine was sup-
plemented in the growth media (Figure 3A, lanes 1 and 2),
indicating that 3-iodo-L-tyrosine was incorporated into
GST at the amber position, although the suppression eﬃ-
ciency was low.
The growth rate of FT3 was found to be just half that of
its parent strain TOP10; the growth rates were determined
as 0.7 and 1.4h
–1 for FT3 and TOP10, respectively, in LB
medium with no antibiotics. Due to this slow growth rate,
the maintenance of four diﬀerent plasmids, and the low
yield of suppression products, FT3 cells were apparently
not useful for yielding large amounts of proteins contain-
ing non-natural amino acids. We tried to circumvent this
problem by further engineering, starting with another
E. coli strain.
Replacement of the E. coli TyrRS–tRNA
Tyr pair by the
M. jannaschii tyrosine pair in strain BL21(DE3)
The E. coli TyrRS and tRNA
Tyr genes were replaced by
the M. jannaschii pair in strain BL21(DE3), an E. coli B
strain. This strain carries the gene encoding the
bacteriophage T7 RNA polymerase in its chromosome,
for the high-level expressions of recombinant proteins.
The order of gene disruptions was not the same as that
with TOP10. In addition, the E. coli amber suppressor
tRNA
Tyr gene was introduced into the chromosome of
BL21(DE3), instead of on a plasmid, to reduce the
number of required plasmids (Figure 1B). First, the cat
gene was substituted for the tyrU gene, and was then
replaced by the sequence encoding the E. coli suppressor
tRNA
Tyr. This step eﬀectively mutated tyrU to the sup-
pressor tRNA
Tyr gene, thus creating the strain FB1 [BL21
DE3 tyrU]. This strain was transformed with pMJY, and
the tyrS gene was then removed from the chromosome to
create FB2 [BL21 DE3 tyrU DtyrS pMJY]. The tyrT and
tyrV genes in FB2 were replaced with one copy of the
suppressor tRNA
Tyr gene. This step created the strain
Figure 2. E. coli DH5a cells, an E. coli K-12 strain, expressing the wild-type E. coli TyrRS from plasmid pEcYS (ﬁlled circles) and those expressing
iodoTyrRS-ec from plasmid pEcIYS (open circles) were grown in the presence of 3-bromo-L-tyrosine (0.5mg/ml) (A) and 3-azido-L-tyrosine
(0.3mg/ml) (B). FT3 cells expressing iodoTyrRS-ec were grown in the absence (ﬁlled circles) and presence (open circles) of 3-bromo-L-tyrosine
(C). The growth was monitored upon the addition of the non-natural amino acid to the growth media.
Figure 3. (A) Site-speciﬁc incorporation of 3-iodo-L-tyrosine (IY) and
3-azido-L-tyrosine (AzY) into GST in FT3 cells (lanes 1–4) and FB3
cells (lanes 5–10). The full-length GST was detected by western
blotting. The growth media were supplemented with IY (lanes 2 and
6) and AzY (lane 8). The wild-type GST (WT) was expressed from
pRGexGST (lane 3) or pRSFGST (lane 10). IPTG(–) means no induc-
tion of the gst expression (lanes 4 and 9). (B) The full-length GST
product, indicated by the arrow, was detected by western blotting in
extracts from the FB3 and BL21(DE3) cells. The applied quantity of
total protein from the extract is indicated at the bottom of each lane.
(C) Fluorescent labeling of rat calmodulin containing 3-azido-L-
tyrosine. Extracts from the cells grown in the absence and presence
of AzY were mixed with the ﬂuorescein-triarylphosphine conjugate
and then applied to SDS–PAGE. The band of calmodulin was
indicated by the arrow.
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tyrT was removed and tyrV was mutated to another copy
of the suppressor tRNA
Tyr gene, expressed from the tyrT
promoter. Thus, the created FB3 strain expresses the
archaeal TyrRS–tRNA
Tyr pair and the E. coli suppressor
tRNA
Tyr, while it lacks E. coli TyrRS and wild-type
tRNA
Tyr. The growth rates of the FB3 and BL21(DE3)
strains were determined as 1.1 and 1.3h
–1, respectively; the
FB3 cells grow almost as fast as the parent strain, and
much faster than FT3. The modiﬁcations to the
BL21(DE3) chromosome had no serious eﬀects on the
viability of the cells.
To demonstrate the site-speciﬁc incorporation of
3-iodo-L-tyrosine into proteins in the strain FB3,
iodoTyrRS-ec was expressed from pEcIYS, and the gst
gene with the amber codon at position 25, gst(Am25),
was expressed from a separate multicopy plasmid,
pRSFGST(Am25), under the control of the T7
promoter. The FB3 strain bearing these plasmids
produced the full-length GST only in the presence of
3-iodo-L-tyrosine, and its yield was signiﬁcantly higher
than that in FT3 cells (Figure 3A, lanes 5 and 6). We
previously used the amber suppressor tRNA
Tyr and the
3-iodo-L-tyrosine-speciﬁc variant of TyrRS (iodoTyrRS-
mj) from M. jannaschii, in order to site-speciﬁcally incor-
porate 3-iodo-L-tyrosine into proteins in E. coli cells (36).
The yield of the full-length product of gst(Am25) in
the presence of 3-iodo-L-tyrosine was then compared
between FB3 cells expressing the iodoTyrRS-ec–E. coli
suppressor tRNA
Tyr pair and the parent BL21(DE3)
cells expressing the iodoTyrRS-mj–archaeal suppressor
tRNA
Tyr pair. Comparable amounts of the full-length
product were detected in the extracts from these cells
(Figure 3B).
Finally, the full-length GST from FB3 cells was
analyzed by mass spectrometry. This amber suppression
product was subjected to a trypsin digestion, for compar-
ison with the peptide data previously obtained for the
wild-type GST (36). The wild-type protein generates a
peptide (Tyr25 peptide) with an average mass correspond-
ing to the theoretical value (m/z=1327.7) for residues
23–33, NSYSPILGYWK (tyrosine at position 25 is
underlined). This peptide was not detected from the
amber suppression product from FB3 cells; instead, a
peptide with an average mass (1453.6) was detected
(Supplementary Figure S2). This value is larger than
that of the Tyr25 peptide by a value (125.9) corresponding
to the mass of an iodine atom, less the mass of a hydrogen
atom, indicating the incorporation of 3-iodo-L-tyrosine at
the amber position.
Genetic encoding of 3-azido-L-tyrosine in the engineered
E. coli cells
A variant of yeast TyrRS, engineered to recognize 3-iodo-
L-tyrosine, reportedly also recognizes 3-azido-L-tyrosine
(37). Using this variant, 3-azido-L-tyrosine was
site-speciﬁcally incorporated into proteins in E. coli
cell-free translation, and was shown to be useful for
site-speciﬁc protein modiﬁcation (25). However, since
this yeast TyrRS variant still recognizes L-tyrosine
eﬃciently, it has not been used for genetically encoding
L-tyrosine derivatives in E. coli cells. We found that
iodoTyrRS-ec also recognizes 3-azido-L-tyrosine eﬃ-
ciently; this amino acid supplemented in the growth
media inhibits the growth of normal E. coli cells
expressing iodoTyrRS-ec, as observed for 3-bromo-L-
tyrosine (Figure 2B). Therefore, iodoTyrRS-ec was used
to incorporate 3-azido-L-tyrosine into proteins in FB3
cells. The full-length product of gst(Am25) was obtained
only in the presence of 3-azido-L-tyrosine, and its yield
was comparable to that of the product with 3-iodo-L-
tyrosine (Figure 3A, lanes 7 and 8). Thus, FB3 cells
expressing iodoTyrRS-ec and the E. coli suppressor
tRNA
Tyr produced the proteins site-speciﬁcally containing
either 3-azido-L-tyrosine or 3-iodo-L-tyrosine, depending
on which amino acid is supplemented in the growth media.
To demonstrate the site-speciﬁc protein modiﬁcation,
rat calmodulin containing 3-azido-L-tyrosine was
produced in FB3 cells expressing the iodoTyrRS-ec–sup-
pressor tRNA
Tyr pair. The full-length product was
expressed from the amber mutant gene, carried on
plasmid pRSFCAM(Am80), only in the presence of
3-azido-L-tyrosine, and was modiﬁed with a ﬂuorescent
probe by the Staudinger–Bertozzi reaction, while the
wild-type protein expressed from plasmid pRSFCAM
was not labeled (Figure 3C). p-Azido-L-phenylalanine
and a L-lysine derivative with the azido group have
already been genetically encoded in E. coli cells (20,38).
Tyrosines tend to reside on the protein surface (39), and
such tyrosines on the surface could be safely replaced with
3-azido-L-tyrosine for site-speciﬁc protein labeling.
Structural basis for 3-azido-L-tyrosine recognition by
iodoTyrRS-ec
E. coli TyrRS was previously engineered into iodoTyrRS-
ec by introducing a double substitution, Tyr37Val and
Gln195Cys (Figure 4A) (21,28). To reveal the structural
basis for the additional recognition of 3-azido-L-tyrosine
by iodoTyrRS-ec, the crystal structure of a complex
between these molecules was determined at 1.8-A ˚ resolu-
tion (PDB ID: 2YXN). The statistics of the data set are
listed in Table 1. The overall structure of the variant
superposed well on the reported crystal structure of
iodoTyrRS-ec complexed with 3-iodo-L-tyrosine (28).
The azido group of 3-azido-L-tyrosine is accommodated
in the space created by the double substitution at the
amino-acid binding pocket (Figure 4B). Although no
enzyme residues appear to make ﬁrm contacts or interac-
tions with the azido group, the shape of the space snugly
ﬁts the substituent. By contrast, in the reported structure,
iodoTyrRS-ec recognizes 3-iodo-L-tyrosine by making van
der Waals contacts between the mutated residues, Val37
and Cys195, and the iodine atom (Figure 4B). The binding
of L-tyrosine to iodoTyrRS-ec, on the other hand, is
weakened by the Tyr37Val substitution, which removes
the hydrogen bond between the phenolic hydroxyl
groups of L-tyrosine and Tyr37 (28) (Figure 4A).
The M. jannaschii iodoTyrRS-mj–suppressor tRNA
Tyr
pair does not incorporate 3-azido-L-tyrosine into proteins
(data not shown), indicating that this archaeal TyrRS
3688 Nucleic Acids Research, 2010,Vol.38, No. 11variant does not recognize 3-azido-L-tyrosine. In the
reported crystal structure of iodoTyrRS-mj complexed
with 3-iodo-L-tyrosine (36), the space created by the muta-
tions just ﬁts the size and shape of the iodine atom, with
ﬁve enzyme residues making van der Waals contacts with
this atom (Figure 4B). The azido substitutent would
collide with Thr158, one of these ﬁve residues, in the
binding pocket of iodoTyrRS-mj, because an azido
group has a more extended shape and is longer than an
iodine atom. This explains the inability of this variant to
recognize 3-azido-L-tyrosine.
CONCLUSION
A variety of tyrosine or phenylalanine derivatives have
been genetically encoded in mammalian cells and E. coli
to facilitate protein science and technology. In mamma-
lian cells, for example, photo-reactive cross-linking amino
acid was used for analyzing protein–protein interactions
(9), and the incorporated 4-azido-L-phenylalanine allowed
the probing of conformational changes in a membrane
protein (40). E. coli cells have been useful for producing
large amounts of proteins containing non-natural amino
acids. The incorporation of 4-azido-L-phenylalanine
allowed the site-speciﬁc protein modiﬁcation with polyeth-
ylene glycol (41), and iodine-atom-containing amino acids
have been utilized in X-ray crystallography (36,42). For
each of these non-natural amino acids, speciﬁc archaeal
and bacterial TyrRS variants both needed to be
developed, when the amino acid was used in the bacterial
and eukaryotic cells. Our engineered E. coli strains
promise to reduce the labor for variant development,
because they can be engineered in the E. coli cells, and
then used in both eukaryotic cells and bacteria. Our
strategy could be applied to other aaRS species, and
would facilitate genetic code expansion in living cells.
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Table 1. Data collection and reﬁnement statistics
Data collection
Space group P3121
Cell dimensions
a, b, c (A ˚ ) 83.16, 83.16, 93.67
, , ( ) 90, 90, 120
Wavelength (A ˚ ) 1.0000
Resolution (A ˚ ) 50–1.8
Measured reﬂections 382492
Unique reﬂections 35502
Redundancy 10.8
Completeness (%) 100.0
I/ (I) 23.0
Rsym (%)
a 11.3
Reﬁnement statistics
Resolution (A ˚ ) 39.26–1.8
Protein atoms 2536
Substrates (per subunit) 1
Water oxygens 295
Mean B value (A ˚ 2) 21.3
Rwork (%)
b 19.9
Rfree (%)
c 24.7
R.m.s. deviations
Bond length (A ˚ ) 0.011
Bond angle ( ) 1.40
aRsym=hkl|Iavg Ii|/hklIi.
bRwork=hkl||FO| |FC|| / hkl|FO|.
cRfree=Rwork using 10% of FO sequestered before reﬁnement.
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